Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Two multicenter trials carried out in the US have demonstrated the efficacy of the oral kinase inhibitors sunitinib and sorafenib in patients with metastatic, cytokine-refractory renal cell carcinoma (RCC). Only 15% of RCC patients typically respond to cytokines, so effective therapies are urgently needed

Today in Hematology/Oncology...keeping you current

Patients' experiences with navigation for cancer care
Patient Education and Counselling, 12/15/09

Anti-platelet Agents
Discovery Medicine, 12/15/09

Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09

Today in Nephrology/Urology...keeping you current

Prostatic Ductal Adenocarcinoma: A Mini Review
Medical Principles and Practice, 12/15/09

Physical Activity and Rapid Decline in Kidney Function Among Older Adults
Archives of Internal Medicine, 12/15/09

Annual Progression of Coronary Calcification in Trials of Preventive Therapies
Archives of Internal Medicine, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address